Β-Resorcylaldehyde attenuates DSS-induced colitis by inhibiting inflammation and oxidative stress through the Keap1/Nrf2/HO-1 pathway
{{output}}
Background: Ulcerative colitis (UC), a bowel condition marked by heightened oxidative stress, ongoing inflammation, and intestinal barrier dysfunction, has limited therapeutic options that are both effective and safe. ... ...
